AscellaHealth CEO, Dea Belazi, Honored as a 2024 PM360 Elite 100 Winner
May 23 2024 - 11:03AM
Business Wire
AscellaHealth, a global partner that delivers proven end-to-end
solutions to both life sciences and healthcare companies to enhance
the quality of life for patients with complex, chronic conditions,
is pleased to announce Dea Belazi, CEO and co-founder,
AscellaHealth, is recognized as a PM360 Elite 100 Winner as a
Transformational Leader in the tenth annual Elite 100. Belazi will
be honored at the ELITE 100 Awards event on June 18th in New York
City. All of the 100 winners are profiled in PM360’s May 2024
issue.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20240523506748/en/
"This honor truly belongs to the entire AscellaHealth team in
recognition of their expertise, dedication and ongoing work that
enables patients with complex, chronic conditions to access
specialty pharmaceuticals and novel therapies that enhance clinical
outcomes,” says Belazi. “It is gratifying to lead a group of
talented professionals who share my commitment to healthcare
transformation and improving the processes for getting critical
healthcare products from manufacturers to patients while ensuring
an efficient flow of funds between payers and pharma.”
The ELITE (Exceptional • Leaders • Innovators • Transformers •
Entrepreneurs) represent the most influential people and teams in
the healthcare and life sciences industries based on their career
accomplishments. Out of more than 500 submissions, 100 winners are
selected by the PM360 editorial staff across various categories
that span every facet of the industry. Nominees for the award are
evaluated based on their accomplishments; testimonials from their
bosses, clients, and colleagues; and supporting evidence that
reflects the impact of their efforts.
About AscellaHealth LLC
AscellaHealth is a global partner that delivers proven
end-to-end solutions to both life sciences and healthcare companies
to enhance quality of life for patients with complex, chronic
conditions. A dedicated team gets critical healthcare products from
manufacturers to patients while ensuring an efficient flow of funds
between payers and pharma. Visit www.AscellaHealth.com.
About PM360
PM360 is the premier, must-read magazine for marketing decision
makers in the pharmaceutical, biotech, diagnostics, and medical
device industries. Published monthly, PM360 is the only journal
that focuses on delivering the full spectrum of practical
information necessary for product managers and pharmaceutical
marketing professionals to succeed in the complex and highly
regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on
issues that directly impact critical decision making, including:
Planning and implementation of cutting-edge strategies, trends, the
latest technological advances, branding/marketing,
advertising/promotion, patient/professional education, sales,
market research, PR, and leadership. Additionally, the “360” in the
title signifies the span of this critical, how-to info with
personal and career insights for an enjoyable and thought-provoking
read.
By providing the full circle of enriching content, PM360 is
truly an indispensable tool for busy and productive marketing
professionals to stay at the top of their game.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240523506748/en/
Media: Nicole Dufour CPR Communications
ndufour@cpronline.com 201.641.1911 x 54